Skip to content

Brookdale Senior Living

US · BKD #2611 by market cap Listed 1970
10.77 -0.13 -1.19%
Live - 5344 symbols - heartbeat 278s ago · 2026-10-08 06:19
Pre-market 10.58 -1.78%
After-hours 10.77 0.00%
Market cap
2.57B
P/B
-89.01
EPS
-1.12
Reader sentiment Are you bullish or bearish on BKD?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio -90.08 Cheap vs history 8th percentile
5-year average -29.90
P/E ratio -18.47 Cheap vs history 4th percentile
5-year average -8.99 · forward 175.83
P/S ratio 0.85 Expensive vs history 86th percentile
5-year average 0.48 · forward 0.89 · #24 of 50 in Medical Care Facilities

Vs. peers Medical Care Facilities

Company Market cap P/E (TTM) P/B Div yield
Brookdale Senior Living (BKD) 2.57B -18.25 -89.01 0.00%
HCA Healthcare (HCA) 95.08B 14.73 -14.32 0.68%
Tenet Healthcare (THC) 20.92B 10.04 4.49 0.00%
Encompass Health (EHC) 12.08B 19.95 4.65 0.62%
DaVita (DVA) 11.28B 14.57 -14.74 0.00%
Fresenius Medical Care (FMS) 11.01B 11.14 0.78 4.13%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value9.89 Economic moatNone UncertaintyHigh

Trading 8.2% above Morningstar's fair value estimate.

Fair value

Brookdale Senior Living Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% premium over our quantitative fair value estimate of $9.89 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's lack of profitability weakens our estimated fair value. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's earnings yield of -1.3% ranks in the bottom 30% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which contributes to our view that shares are expensive.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of -1.1%, for example, ranks in the bottom 10% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 06:19:20 · For reference only, not investment advice and not tailored to your situation.